| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701759 | Journal of Thoracic Oncology | 2016 | 6 Pages |
Abstract
The current study was specifically intended to investigate whether ypN categories after trimodality therapy agree with International Association for the Study of Lung Cancer's new pN subclassification. Through the current study, the authors have confirmed that ypN downstaging to ypN0-1 from initial N2 stage is a favorable factor with respect to OS and raised the need for refinement of ypN subcategorization after trimodality therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hakyoung MD, Yong Chan MD, PhD, Hongryull MD, PhD, Dongryul MD, Jae Myoung MD, Jong-Mu MD, PhD, Jin Seok MD, PhD, Myung-Ju MD, PhD, Keunchil MD, PhD, Yong Soo MD, PhD, Jhingook MD, PhD, Jae Ill MD, PhD, Young Mog MD, PhD, Minju MD, Jungho MD, PhD,